You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 26, 2025

Drug Price Trends for NDC 71921-0170


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 71921-0170

Drug NameNDCPrice/Unit ($)UnitDate
SUMATRIPTAN 20 MG NASAL SPRAY 71921-0170-61 22.12141 EACH 2025-04-23
SUMATRIPTAN 20 MG NASAL SPRAY 71921-0170-61 22.32471 EACH 2025-03-19
SUMATRIPTAN 20 MG NASAL SPRAY 71921-0170-61 18.91294 EACH 2025-02-19
SUMATRIPTAN 20 MG NASAL SPRAY 71921-0170-61 16.72757 EACH 2025-01-22
>Drug Name>NDC>Price/Unit ($)>Unit>Date
Showing 1 to 4 of 4 entries

Best Wholesale Price for NDC 71921-0170

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
SUMATRIPTAN 20MG/SPRAY SOLN,NASAL,0.1ML AvKare, LLC 71921-0170-61 6 126.89 21.14833 2023-06-15 - 2028-06-14 FSS
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 1 to 1 of 1 entries

Market Analysis and Price Projections for NDC 71921-0170: Sumatriptan Nasal Spray

In the ever-evolving landscape of pharmaceutical markets, understanding the dynamics of specific drugs is crucial for healthcare professionals, investors, and policymakers. This article delves into the market analysis and price projections for the drug identified by National Drug Code (NDC) 71921-0170, which corresponds to Sumatriptan nasal spray. As we navigate through the complexities of drug pricing and market trends, we'll explore the factors influencing its future in the pharmaceutical industry.

Understanding NDC 71921-0170: Sumatriptan Nasal Spray

Sumatriptan nasal spray, identified by NDC 71921-0170, is a medication used for the acute treatment of migraine with or without aura in adults[5]. As a serotonin receptor agonist, it belongs to a class of drugs known as triptans, which are specifically designed to alleviate migraine symptoms.

Key Features of Sumatriptan Nasal Spray

  • Indication: Acute treatment of migraine in adults
  • Administration: Nasal spray formulation
  • Manufacturer: Florida Pharmaceutical Products, LLC
  • Prescription Status: Human prescription drug

Current Market Position

To understand the potential future of Sumatriptan nasal spray, it's essential to examine its current market position within the broader pharmaceutical landscape.

Specialty Pharmaceutical Classification

Sumatriptan nasal spray falls under the category of specialty pharmaceuticals, which are typically used to treat complex, chronic conditions. This classification is significant because specialty drugs are a major driver of pharmaceutical spending and price increases.

The pharmaceutical market is projected to see a 3.8% increase in drug prices in 2024, primarily driven by specialty pharmaceuticals[1].

Price Trends in Specialty Pharmaceuticals

Specialty pharmaceuticals, including drugs like Sumatriptan nasal spray, are experiencing notable price trends:

  • Projected Increase: Around 4.18% for specialty medications in 2024[1][3][4]
  • Market Dominance: Specialty drugs make up the majority of the top 15 medications in terms of spend among pharmacy program participants[1]

Factors Influencing Price Projections

Several key factors will likely influence the price projections for Sumatriptan nasal spray (NDC 71921-0170) in the coming years.

1. Overall Pharmaceutical Market Trends

The broader pharmaceutical market is experiencing significant changes that could impact the pricing of Sumatriptan nasal spray:

  • Drug Price Inflation: A 3.8% overall increase in drug prices is expected in 2024[1]
  • Specialty Drug Focus: Increased emphasis on complex and chronic condition treatments[1][3][4]

2. Research and Development Advancements

The pharmaceutical industry is witnessing rapid advancements in research and development methodologies:

  • AI Integration: Accelerated clinical trial enrollment and reduced development costs[2]
  • Data-Driven Approaches: Improved efficiency in patient recruitment and trial design[2]

3. Supply Chain Optimization

Efforts to streamline supply chains could impact the pricing structure of drugs like Sumatriptan nasal spray:

  • Sustainability Initiatives: Focus on building resilient and efficient supply chains[2]
  • Digital Tools: Implementation of AI and data analytics for supply chain management[2]

4. Regulatory Environment

The regulatory landscape plays a crucial role in determining drug prices:

  • Medicare Negotiations: Potential for significant price reductions if selected for Medicare's negotiation program[3][4]
  • Policy Changes: The incoming administration's healthcare policies may influence pricing strategies[7]

5. Competition and Market Dynamics

The presence of competitors and market forces will shape the pricing strategy for Sumatriptan nasal spray:

  • Biosimilars: Potential introduction of biosimilar alternatives could stabilize or decrease prices[3][4]
  • Market Demand: Changing patterns in migraine treatment could affect demand and pricing

Price Projections for NDC 71921-0170

Based on the analyzed factors and market trends, we can make the following projections for Sumatriptan nasal spray (NDC 71921-0170):

Short-Term Projections (1-2 Years)

In the immediate future, Sumatriptan nasal spray is likely to see a price increase in line with specialty pharmaceutical trends:

  • Estimated Increase: 4.18% annually, aligning with specialty drug projections[1][3][4]
  • Driving Factors: Market demand, R&D costs, and overall pharmaceutical inflation

Medium-Term Projections (3-5 Years)

The medium-term outlook for Sumatriptan nasal spray pricing is more complex:

  • Potential Stabilization: Introduction of biosimilars or generic alternatives may lead to price stabilization
  • Regulatory Impact: Medicare negotiations could significantly alter pricing if the drug is selected for the program

Long-Term Projections (5+ Years)

Long-term projections are subject to greater uncertainty but may include:

  • AI-Driven Efficiencies: Potential for cost reductions due to improved R&D and manufacturing processes
  • Market Saturation: Possible price decreases as the market for migraine treatments evolves

Comparative Analysis

To better understand the pricing dynamics of Sumatriptan nasal spray, it's helpful to compare it with broader market trends:

U.S. vs. International Pricing

The U.S. pharmaceutical market often sees higher prices compared to international markets:

  • U.S. Price Trend: 14% increase between 2017 and 2022[4]
  • International Trend: 9% decrease in the world (excluding U.S.) and 7% decrease in OECD countries (excluding U.S.) during the same period[4]

Price Multiplier

In 2022, the average price per unit in the U.S. was 5.5 times as high as in the OECD (excluding U.S.) and 7.7 times as high as the rest of the world[4].

This significant price differential suggests that Sumatriptan nasal spray may be priced considerably higher in the U.S. compared to international markets.

Market Strategies for Stakeholders

Given the projected market dynamics for Sumatriptan nasal spray, various stakeholders should consider the following strategies:

For Manufacturers

  • Invest in R&D: Focus on developing improved formulations or delivery methods to maintain market share
  • Optimize Supply Chains: Implement AI and data analytics to reduce costs and improve efficiency
  • Prepare for Negotiations: Develop strategies to navigate potential Medicare price negotiations

For Healthcare Providers

  • Monitor Alternatives: Stay informed about potential biosimilars or generic versions entering the market
  • Patient Education: Provide information on cost-effective migraine treatment options
  • Formulary Management: Regularly review and adjust formularies based on pricing trends

For Payers

  • Negotiate Contracts: Leverage market data to secure favorable pricing agreements
  • Implement Value-Based Models: Explore outcomes-based pricing structures for migraine treatments
  • Encourage Biosimilar Adoption: Develop policies that promote the use of cost-effective alternatives when available

For Investors

  • Diversify Portfolios: Balance investments across different pharmaceutical sectors to mitigate risks
  • Monitor Regulatory Changes: Stay informed about policy shifts that could impact drug pricing
  • Analyze Market Trends: Keep a close eye on migraine treatment innovations and market demand

Future Market Landscape

The future market for Sumatriptan nasal spray and similar migraine treatments is likely to be shaped by several key trends:

1. Personalized Medicine

Advancements in genetic testing and biomarker identification may lead to more targeted migraine treatments, potentially affecting the market position of Sumatriptan nasal spray.

2. Digital Health Integration

The integration of digital health technologies, such as migraine tracking apps and telemedicine platforms, could influence prescription patterns and patient preferences.

3. Novel Delivery Methods

Innovations in drug delivery systems may introduce new competitors or lead to improved versions of existing treatments, including Sumatriptan.

4. Global Market Expansion

Increased access to healthcare in developing markets may expand the global demand for migraine treatments, potentially affecting pricing strategies.

5. Regulatory Evolution

Changes in drug approval processes and pricing regulations, both in the U.S. and internationally, will continue to shape the market landscape for migraine medications.

Key Takeaways

  • Sumatriptan nasal spray (NDC 71921-0170) is likely to see price increases in line with specialty pharmaceutical trends, projected at around 4.18% annually in the short term.
  • Long-term pricing will be influenced by factors such as biosimilar competition, regulatory changes, and advancements in R&D and manufacturing processes.
  • The U.S. market for Sumatriptan nasal spray is expected to maintain significantly higher prices compared to international markets.
  • Stakeholders should prepare for potential Medicare price negotiations and the impact of evolving healthcare policies.
  • Future market dynamics will be shaped by personalized medicine, digital health integration, and novel delivery methods.
  • Manufacturers, healthcare providers, payers, and investors must adapt their strategies to navigate the changing landscape of migraine treatments.

FAQs

  1. How does the pricing of Sumatriptan nasal spray compare to other migraine treatments? While specific comparisons depend on various factors, as a specialty pharmaceutical, Sumatriptan nasal spray is likely to be priced higher than non-specialty migraine treatments. However, its effectiveness and convenience may justify the cost for many patients.

  2. Will the introduction of biosimilars significantly impact the price of Sumatriptan nasal spray? If biosimilars for Sumatriptan nasal spray enter the market, they could lead to price stabilization or decreases. However, the timing and extent of this impact will depend on regulatory approvals and market adoption rates.

  3. How might AI and data analytics affect the future pricing of drugs like Sumatriptan nasal spray? AI and data analytics are expected to improve R&D efficiency and supply chain management, potentially leading to cost reductions in drug development and production. This could eventually translate to more stable or even reduced prices for consumers.

  4. What role do Medicare negotiations play in determining the price of Sumatriptan nasal spray? If Sumatriptan nasal spray is selected for Medicare's negotiation program, it could see significant price reductions. However, this depends on whether the drug meets the criteria for inclusion in the program and the outcome of negotiations.

  5. How can patients manage the cost of Sumatriptan nasal spray if prices continue to rise? Patients can explore options such as patient assistance programs, generic alternatives (if available), insurance coverage optimization, and discussing cost-effective treatment plans with their healthcare providers.

Sources cited: [1] https://www.drugpatentwatch.com/p/drug-price/ndc/71921-0308 [2] https://www.pwc.com/us/en/industries/pharma-life-sciences/pharmaceutical-industry-trends.html [3] https://aspe.hhs.gov/sites/default/files/documents/4326cc7fe43bc11770598cf2a13f478c/international-market-size-prices.pdf [4] https://aspe.hhs.gov/sites/default/files/documents/277371265a705c356c968977e87446ae/international-price-comparisons.pdf [5] https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=267dadc1-6960-4d8b-88ef-86be9c5f7159 [7] https://www.labiotech.eu/in-depth/biotech-trends-2025/

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.